Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005719-89Phase 3Completed
Phase 3, randomised, double-blind trial in sleep disorder comparing Melatonin with Placebo (2 arms). Primary endpoint: Vitality improvement (RAND SF-36). Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005719-89.